The global nephrology and urology devices market size was valued at USD 5.24 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.8% from 2022 to 2030. Moreover, due to the recent COVID-19 outbreak, healthcare facilities such as hospitals have been exhausted by a large influx of such patients; therefore, many countries have postponed elective surgeries and other healthcare procedures for an indefinite period. Additionally, the demand for renal disease treatment products used in home settings has increased as patients suffering from chronic kidney diseases are seeking home treatment options and/or outpatient clinics. Furthermore, the presence of a large number of hospitals in the U.S., coupled with a well-developed healthcare infrastructure, is another factor contributing to industry growth.

Among the major tests, the foremost test for the diagnosis of kidney disease includes a blood test, which helps understand how well the kidneys work. It measures levels of a waste product called creatinine in the blood. Furthermore, the demand for these tests is projected to increase as the incidence of CKD is high and growing in many parts of the world. The global incidence of end-stage renal disease (ESRD) is high and growing at a significant rate. Thus, it creates more opportunities for market growth.